$3.5M gene therapy for hemophilia gets FDA approval
U.S. health regulators have approved the first gene therapy for hemophilia, a blood-clotting disorder with few treatment options. The maker of the one-time treatment said the drug…
U.S. health regulators have approved the first gene therapy for hemophilia, a blood-clotting disorder with few treatment options. The maker of the one-time treatment said the drug…